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SEPSIS WITH ACUTE KIDNEY INJURY 
  
Abstract: 
Sepsis is one of the most common causes of mortality in hospital and ICU 
admission cases. It is suggested that sepsis with AKI is associated with higher 
mortality and morbidity when compared with Non-septic Acute kidney injury 
cases. AKI is seen in 19% of moderate sepsis, 23% with severe sepsis and 51% 
with septic shock.so, with increasing severity of sepsis there is increase in 
incidence of AKI and increase in mortality. Mortality is higher in males, older 
age group associated with co-morbid illness. In our study, we study about the 
profile of AKI in septic cases. Sepsis is classified into moderate, severe and 
septic shock based on American college of thoracic society and its clinical 
outcomes are assed based on available parameters. AKI is divided into risk, 
injury, failure, loss and ESRD based on RIFLE classification and they are studied 
regarding the outcome, response to treatment, mortality and morbidity rates. 
Renal replacement therapy is the treatment of choice, when patient is anuric, 
raising azotaemia and resistant hypertension with pulmonary edema the ideal 
therapy is haemodialysis.  
 
Keywords: Sepsis, Acute kidney injury, renal replacement therapy, RIFLE 
classofocation. 
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INTRODUCTION 
Acute renal failure occurs in approximately 19 percent of Patients 
with moderate sepsis, 23 percent with severe sepsis, and 51 percent with 
septic shock when blood cultures are positive1,2.  
A progressive increase in the incidence of acute respiratory 
distress syndrome also occurs with moderate and severe sepsis and 
septic shock. In the United States, an estimated 700,000 cases of sepsis 
occur each year, resulting in more than 210,000 deaths; this number 
accounts for 10 percent of all deaths annually and exceeds the number 
of deaths due to myocardial infarction3. In India, studies in patients with 
sepsis with AKI are lacking. Majmudar et al, from india also 
demonstrated the same amount of incidence of sepsis in hospital 
admitted patients. The combination of acute renal failure and sepsis is 
associated with 70 percent mortality, as compared with 45 percent 
mortality among patients with acute renal failure alone. 
Thus, the combination of sepsis and acute renal failure constitutes 
a particularly serious medical problem4. Substantial discovery has been 
made towards understanding the mechanisms whereby sepsis is 
associated with a high incidence of acute renal failure. The cytokine-
mediated induction of nitric oxide synthesis that occurs in sepsis 
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decreases systemic vascular resistance5. This arterialvasodilatation 
predisposes patients with sepsis to acute renal failure, the need for 
mechanical ventilation, and ultimately, increased mortality. 
Patients who have a combination of sepsis and acute renal failure 
may have some effects of systemic arterial vasodilatation, such as 
altered Starling forces in the capillaries, pulmonary edema, and hypoxia, 
a need for mechanical ventilation, acute respiratory distress syndrome, 
and multiple- organ dysfunction syndrome, which together may increase 
mortality to more than 80 percent6,8. 
In the background, the statistical data available on sepsis patients 
going in for acute kidney injury and then renal failure is entirely western 
data and there are not many studies done in india to prove their 
correlation and significance. There was an article in clinical journal of 
critical care medicine from AMRI hospitals, kolkatta stating about the 
emerging significance of sepsis with acute kidney injury and its 
increasing mortality. Still, there are no other significant studies done in 
India. Therefore, this study will throw some light on the sepsis patients 
going in for acute kidney injury and their various profile and clinical 
outcome of these patients. 
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REVIEW OF LITERATURE 
Definition of sepsis:  
Animals mount both local and systemic responses to microbes 
that traverse epithelial barriers and invade underlying tissues. Fever or 
hypothermia, leukocytosis or leukopenia, tachypnea, and tachycardia are 
the cardinal signs of the systemic response often called the systemic 
inflammatory response syndrome (SIRS)11. 
SIRS may have an infectious or a non-infectious aetiology. If 
infection is suspected or proven, a patient with SIRS is said to have 
sepsis. When sepsis is associated with dysfunction of organs distant 
from the site of infection, the patient has severe sepsis. Severe sepsis 
may be accompanied by hypotension or evidence of hypoperfusion. 
When hypotension cannot be corrected by infusing fluids, the diagnosis 
is septic shock. 
Severe sepsis can be a response to any class of microorganism. 
Microbial invasion of the bloodstream is not essential for the 
development of severe sepsis, since local inflammation can also elicit 
distant organ dysfunction and hypotension. In fact, blood cultures yield 
bacteria or fungi in only ~20–40% of cases of severe sepsis and 40–70% 
of cases of septic shock. Individual gram-negative or gram-positive 
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bacteria account for ~70% of these isolates; the remainder are fungi or a 
mixture of microorganisms. In patients whose blood cultures are 
negative, the etiologic agent is often established by culture or 
microscopic examination of infected material from a local site. In some 
case series, a majority of patients with a clinical picture of severe sepsis 
or septic shock have had negative microbiologic data. 
TYPE OF SEPSIS CHARACTERISTICS 
1.MODERATE SEPSIS 1.Temp >38deg cel or <36deg cel 
2.heart rate>90/mt 
3.RR>24/minute 
4.wbc count >12000 or < 4000 
Cell/cumm     
5.immature band forms plus  
Evidence of infection 
2.SEVERE SEPSIS Sepsis +  
One organ dysfunction 
1.CVS-- SBP <90mmhg or 
MAP<70mmhg responds to IVF 
2.RENAL—UO<5ml/kg/hr despite 
IVF 
5 
 
3.haematological—platelet count 
<80,000/l or 50% reduction from 
previous value for the past 3 days 
4.unexplained metabolic acidosis 
5.adequete fluid resuscitation 
3.SEPTIC SHOCK Sepsis with hypotension 
SBP<90mmhg or MAP<70mmhg 
despite adequate fluid resuscitation 
and inotropes. 
 
Sepsis is a complication of an infectious process that is 
characterized by systemic inflammation with widespread tissue injury. 
The use of the word sepsis has long been a source of confusion because 
it is used interchangeably with the terms bacteremia, sepsis syndrome, 
severe sepsis, or even septic shock The expert panel of the 
ACCP/SCCM (American College of Chest Physicians/Society of 
Critical Care Medicine11) provided a conceptual and practical 
framework to define the systemic response to infection that falls under 
the general term of “sepsis”11. The panel classified septic patients into 
subgroups of increasing severity and mortality risk. 
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Acute renal injury: 
Deterioration of renal function over days to weeks is called acute renal 
injury69.  
RIFLE CLASSIFICATION10: 
 GFR criteria Urine output criteria 
Risk  
 
Increased cr×1.5 or 
GFR>25% decrease or 
absolute increase in 
sr.cr of 0.3mg/dl 
<5ml/kg/hr for 6hrs 
Injury 
 
Increased cr×2 or GFR 
>50% decrease 
<5ml/kg/hr for12hrs 
Failure 
 
Increased cr×3 or 
GFR>75% decrease or 
sr cr>4mg/dl 
<3ml/kg/hr for 12hrs 
or anuria for 12 hrs 
Loss 
 
Persistent AKI >4 
Weeks 
  
End stage renal 
disease 
Persistent renal failure 
for >3months 
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Haemodynamics in sepsis patients: 
The hemodynamic hallmark of sepsis is generalized arterial 
vasodilatation with an associated decrease in systemic vascular 
resistance. Arterial under filling due to arterial vasodilatation occurs in 
several clinical circumstances, including sepsis, and is associated with 
activation of the neurohumoral axis and an increase in cardiac output 
secondary to the decreased cardiac afterload. Activation of the 
sympathetic nervous system and the renin–angiotensin–aldosterone axis, 
the nonosmotic release of vasopressin, and an increase in cardiac output 
are essential in maintaining the integrity of the arterial circulation in 
patients with severe sepsis and septic shock but may lead to acute renal 
failure8,9,10,11. The arterial vasodilatation that accompanies sepsis is 
mediated, at least in part, by cytokines that up-regulate the expression of 
inducible nitric oxide synthase, as compared with constitutive 
endothelial nitric oxide synthase, is more profound and prolonged. 
Moreover, vascular resistance to the pressor response to norepinephrine 
and angiotensin II occurs during sepsis and is attributable in part to the 
potent vasodilatory effect of nitric oxide12,14,15. In addition, an increase 
in plasma concentrations of hydrogen ions and lactate and a decrease in 
ATP in vascular smooth-muscle cells during septic shock activate the 
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ATP-sensitive potassium channels (K ATP channel)16,17. The resultant 
potassium efflux through the K ATP channels causes hyperpolarization 
of the vascular smooth-muscle cells with closure of the vascular 
smooth-muscle cells with closure of the voltage-gated calcium channels 
in the membrane. Since the vasoconstrictor effects of norepinephrine12 
and angiotensin II5 depend on open calcium channels, vascular 
resistance to these pressor hormones can occur along with lactic acidosis 
in patients with sepsis. Furthermore, the high endogenous levels of these 
vasoactive hormones during sepsis may be associated with down-
regulation of their receptors which would result in a lessening of their 
effects on the vasculature12,13.  
Effects of systemic arterial vasodilation on body fluid volume and 
Starling forces: 
The difference between the oncotic and hydrostatic pressures 
within the vasculature and interstitium (Starling forces) determines 
whether plasma water remains within the vasculature or leaks out into 
the interstitium. Experimental studies in rats have examined the effect of 
arterial vasodilatation on Starling forces, albumin distribution, and 
body-fluid volume in normal animals30. The administration of the potent 
arterial vasodilator minoxidil was shown to cause sodium and water 
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retention with resultant expansion of plasma and interstitial volume. 
With the use of Guyton’s subcutaneous capsule, which is able to 
measure interstitial pressure, arterial vasodilatation in a rat model was 
shown to reverse the normally negative pressure within the interstitium. 
Moreover, during intravenous saline loading, interstitial pressure 
increased in animals without vasodilatation, whereas the elevated 
interstitial pressure in the animals that had vasodilatation did not 
increase further. The fall in interstitial pressure that occurred with the 
intravenous administration of hyper-oncotic albumin in the normal 
animals did not occur in the animals with vasodilatation. This latter 
effect may be due to the  increased distribution of albumin within the 
interstitial space that occurs with arterial vasodilatation. The pulmonary 
bed is particularly prone to collect interstitial fluid in this situation. If 
applied to humans, these findings would indicate that patients with 
sepsis who have vasodilatation are susceptible to noncardiogenic 
pulmonary edema.  
Neveu et al6 performed a prospective study involving 345 patients 
who had acute renal failure with or without sepsis. The most dramatic 
differences were the increased requirement for mechanical ventilation 
(70 percent vs. 47 percent, P=0.001) and the higher mortality (74.5 
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percent vs. 45.2 percent, P<0.001) in the patients with sepsis. There are 
sequences of events that can occur with overly aggressive fluid 
administration, which results in increases in interstitial volume in 
patients with sepsis and acute renal failure who have vasodilatation. 
Sepsis and endotoxemia: 
There is experimental evidence that in early sepsis related acute 
renal failure, the predominant pathogenetic factor is renal 
vasoconstriction with intact tubular function, as demonstrated by 
increased reabsorption of tubular sodium and water. Thus, intervention 
at this early stage may prevent progression to acute tubular necrosis. For 
example, if endotoxin is infused into a conscious-rat model, the early 
events include a fractional excretion of sodium of less than 1 percent, 
indicating good tubular function. Fractional excretion of sodium is 
calculated as [(urine sodium¬plasma creatinine) ÷ (plasma 
sodium¬urine creatinine)] ¬100. This level of fractional excretion may 
result in prerenal azotemia22,23. If this prerenal azotemic state is 
persistent, the fractional excretion of sodium increases, indicating 
tubular dysfunction that may progress to established acute tubular 
necrosis. Although the activation of the neurohumoral axis during the 
arterial vasodilatation that occurs in sepsis is critical in maintaining 
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arterial circulatory integrity it is associated with renal vasoconstriction31. 
Plasma concentrations of catecholamines and activation of the renin–
angiotensin–aldosterone system are known to be heightened in cases of 
sepsis10 and septic shock11. This pattern of hormonal activation has been 
observed in a normotensive murine model of endotoxemia induced with 
lipopolysaccharide (5 mg per kilogram of body weight)33. In this same 
model, renal denervation afforded considerable protection against the 
decrease in the glomerular filtration rate during the initial 16 hours of 
endotoxemia. Such studies indicate that the effects of these vasoactive 
hormones on the kidney are, at least in some measure, neurally mediated 
and may contribute to the acute renal failure seen in cases of sepsis.  
Another pressor hormone that has been observed to be elevated in 
sepsis is endothelin, a potent vasoconstrictor. Renal vasoconstriction in 
sepsis seems to be due, at least in part, to the ability of tumor necrosis 
factor to release endothelin34. Indeed, an intrarenal injection of 
antiserum to endothelin- 1 in a rat model was capable of reversing the 
decrease in the glomerular filtration rate induced by endotoxin. During 
endotoxemia, endothelin may also cause an endotoxemia, generalized 
leakage of fluid from the capillaries and thereby diminish plasma 
volume36. The vasodilatory effect of constitutive endothelial nitric oxide 
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Synthase within the kidney might be expected to lessen the renal 
vasoconstriction induced by norepinephrine, angiotensin II, and 
endothelin during sepsis. However, the results of in vitro studies showed 
that the increase in the plasma nitric oxide concentration stimulated by 
inducible nitric oxide synthase during endotoxemia down-regulated 
endothelial nitric oxide synthase within the kidney37. 
When cytokines activated inducible nitric oxide synthase, 
however, not only did the plasma nitric oxide concentration increase, 
but also the expression of inducible nitric oxide synthase increased in 
the renal cortex38. In association with this increased expression of 
inducible nitric oxide synthase, a progressive increase in cGMP in the 
renal cortex occurred during the initial 16 hours after exposure to 
endotoxin. At 24 hours, however, the plasma nitric oxide concentration 
remained high, though renal cGMP had decreased. Since cGMP is the 
secondary messenger for nitric oxide–mediated arterial vasodilatation, 
the down regulation of this enzyme at 24 hours may also contribute to 
renal vasoconstriction during sepsis. 
Endothelial damage occurs during sepsis and may be associated 
with microthrombi and an increased concentration of von Willebrand 
factor in the circulation39. Sepsis-related impairment of the endothelium 
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may also attenuate or abolish the normal effect of endothelial nitric 
oxide synthase in the kidney to counteract the vasoconstrictor effects of 
norepinephrine, endothelin, and angiotensin II. The study of knockout 
mice, in which the expression of either endothelial nitric oxide synthase 
or inducible nitric oxide synthase has been ablated, has been helpful in 
elucidating the importance of endothelial damage during sepsis. Since 
there is no specific inhibitor of endothelial nitric oxide synthase, the 
effect of endotoxin (lipopolysaccharide) was tested in endothelial nitric 
oxide synthase–knockout mice, which have a significant increase in 
blood pressure and renal vascular resistance as compared with normal 
(control) mice. A small dose of endotoxin, which did not alter the 
glomerular filtration rate in the control mice, caused a profound 
decrease in the glomerular filtration rate in these knockout mice40.  
Endotoxemia:  
Tumor Necrosis Factor and Reactive Oxygen Species 
Studies have also been undertaken in inducible nitric oxide 
synthase–knockout mice to determine the role of the high plasma nitric 
oxide concentration in the acute renal failure that is associated with 
endotoxemia. A dose of endotoxin (lipopolysaccharide) of 5 mg per 
kilogram causes a large and progressive rise in the plasma nitric oxide 
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concentration in the normotensive mouse model by means of inducible 
nitric oxide synthase. However, in mice in which inducible nitric oxide 
synthase is ablated, this same dose of endotoxin fails to cause an 
increase in plasma nitric oxide. Nevertheless, these knockout mice still 
have a decrease in the glomerular filtration rate after receiving 
endotoxin, suggesting that cytokines such as tumor necrosis factor can 
cause renal vasoconstriction even in the absence of inducible nitric 
oxide synthase38. The role of tumor necrosis factor in endotoxin-related 
acute renal failure has been tested in both animal and human studies. 
Endotoxemia is known to be associated with the generation of 
oxygen radicals and thus may contribute to the early vasoconstrictor 
phase of acute renal failure. Endogenous scavengers of reactive oxygen 
species can attenuate renal tubular injury or renal vascular injury (or 
both) that is caused by re- active oxygen species during 
endotoxemia41,42. However, the levels of the messenger RNA and 
protein of the endogenous scavenger extracellular superoxide dismutase, 
which is found predominantly in blood vessels and the kidney, have 
been noted to be decreased in mice during endotoxemia. 
Oxygen radicals also scavenge nitric oxide to produce 
peroxynitrite, an injurious reactive oxygen species. Furthermore, the 
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decrease in endothelial nitric oxide synthase in the kidney when there is 
oxidant-related endothelial damage may contribute to the early 
vasoconstrictor phase of acute renal failure. Sepsis and endotoxemia 
with acute renal failure can lead to early noncardiogenic pulmonary 
edema, hypoxia and the need for mechanical ventilation. With 
prolonged ventilatory support, acute respiratory distress syndrome, 
multiple-organ dysfunction syndrome, and an extremely high mortality 
can occur. The goal is to intervene early to prevent excessive fluid 
administration and to lessen fluid overload by hemofiltration. This will 
prevent the need for long-term mechanical ventilation that could lead to 
damage to the pulmonary capillaries. It could also prevent tissue 
hypoxia and the acute respiratory distress syndrome and reduce the risk 
of death41,43. 
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Endotoxemia stimulates the induction of nitric oxide synthase, 
which leads to nitric oxide–mediated arterial vasodilation.The resultant 
arterial underfilling is sensed by the baroreceptors and results in an 
increase in sympathetic outflow and the release of arginine vasopressin 
from the central nervous system, with activation of the renin–
angiotensin–aldosterone system (RAAS)37. These increases in renal 
sympathetic and angiotensin activities lead to vasoconstriction with 
sodium and water retention and a predisposition to acute renal failure. 
Cytokines, Chemokines, and Adhesion Molecules: 
The early vasoconstrictor phase of acute renal failure during 
endotoxemia may be followed by a pro-inflammatory phase, although 
there is probably an overlap in these processes. It is known that caspase 
activates both interleukin-1 and interleukin-18 cytokines, and the 
resultant up-regulation of adhesion molecules contributes to neutrophil 
infiltration during endotoxemia. The importance of caspase in 
endotoxemia has been underscored by the observation that caspase-1–
knockout mice are protected against renal failure that is induced by 
either ischemia45 or endotoxemia46. Several chemokines are also 
expressed during endotoxemia in association with neutrophil and 
macrophage infiltration into the glomeruli and interstitium. The complex 
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composed of a lipopolysaccharide and the lipopolysaccharide-binding 
protein activates the membrane-CD14 and toll-like receptors on cells, 
which up-regulate nuclear factork B (NFk B), a nuclear transcription 
factor for the promoters of multiple cytokines, chemokines, and 
adhesion molecules47. Activation of NFk B may therefore be a critical 
factor in the proinflammatory phase that involves a cytokine, 
chemokine, and adhesion molecule “storm,” which leads to acute renal 
failure and an increased death rate. Blocking agents for NFk B exist that 
could protect against endotoxemia better than targeting any individual 
cytokine, chemokine, or adhesion molecule48. These substances need to 
be studied both in experimental models and in clinical studies in humans 
with concurrent sepsis and acute renal failure. 
Complement pathways are activated during sepsis by bacterial 
products such as lipopolysaccharide, by bacterial products such as 
lipopolysaccharide, C-reactive protein, and other stimuli. Complement 
C5a that is generated during sepsis seems to have procoagulant 
properties, and blocking C5a and C5a receptor in a rodent model of 
sepsis has been shown to improve survival49,50,51. 
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Disseminated intravascular coagulation: 
Sepsis affects the expression of complement, coagulation, and the 
fibrinolytic cascade. Sepsis can be viewed as a procoagulant state that 
can lead to disseminated intravascular coagulation with consumptive 
coagulopathy, thrombosis, and ultimately haemorrhage.  
Disseminated intravascular coagulation has been associated with 
glomerular microthrombi and acute renal failure54. Prospective, 
randomized trials have been undertaken to evaluate methods of 
intervening in the procoagulant process associated with sepsis. A major 
prospective, randomized study, the PROWESS (Recombinant Human 
Activated Protein C Worldwide Evaluation in Severe Sepsis) trial, 
showed that recombinant human activated protein C (drotrecogin alfa) 
significantly improved survival in patients with severe sepsis, as 
compared with those given placebo (75.3 percent vs. 68.3 percent, 
P=0.006)55. 
Early intervention is always better:  
Since the early vasoconstrictor phase of sepsis and acute renal 
failure is potentially reversible, it should be an optimal time for 
intervention. However, clinical studies performed in patients up to 72 
hours after admission to the intensive care unit, in which attempts were 
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made to optimize hemodynamics and monitor the patients with a 
pulmonary-artery catheter, not only were negative56,57,58,59 but showed 
increased mortality among patients with sepsis. In contrast, a 
randomized study of 263 patients with a mean serum creatinine 
concentration of 2.6 mg per deciliter (230 μmol per liter) on admission 
to the emergency department showed that early goal directed therapy 
during the first six hours after admission was effective60. The central 
venous oxygen saturation was continuously monitored as goal directed 
therapy was instituted; in patients assigned to such interventions, the 
multiorgan dysfunction score decreased significantly and in-hospital 
mortality decreased (30.5 percent, as compared with 46.5 percent in the 
control patients, who received standard care; P=0.009). The goal-
directed approach included early volume expansion and administration 
of vasopressors to maintain mean blood pressure at or above 65 mm Hg 
and transfusion of red cells to increase the hematocrit to 30 percent or 
more if central venous oxygen saturation was less than 70 percent. If 
these interventions failed to increase central venous oxygen saturation to 
greater than 70 percent, then therapy with dobutamine was instituted.  
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Hyperglycaemia and insulin:  
Hyperglycemia impairs the function of leukocytes and 
macrophages. A randomized study of 1548 patients compared the use of 
insulin to control blood glucose levels tightly (maintaining blood 
glucose levels between 80 and 110 mg per deciliter [4.4 and 6.1 mmol 
per liter]) with conventional treatment (the use of insulin only if the 
blood glucose levels exceeded 215 mg per deciliter [11.9 mmol per 
liter], with the aim of maintaining glucose levels between 180 and 220 
mg per deciliter [10.0 and 12.2 mmol per liter]61. The group assigned to 
tight control of blood glucose levels showed a decrease in mortality in 
the intensive care unit as compared with the group receiving 
conventional treatment (4.6 percent vs. 8 percent, P<0.04), a 46 percent 
decrease in positive blood cultures, and a 41 percent decrease in acute 
renal failure requiring dialysis or hemofiltration. Multiple-organ failure 
with a proven focus of sepsis was also decreased (8 cases vs. 33 cases, 
P=0.02). Recent studies further support the importance of controlling 
blood glucose in critically ill patients but suggest a less stringent goal of 
maintaining blood glucose  at a level of 145 mg per deciliter (8.0 mmol 
per liter) or less62.  Arginine vasopressin (AVP) and hydrocortisone (50 
mg every six hours for seven days) may be effective therapy for pressor-
resistant hypotension and may decrease the likelihood of acute renal 
failure during septic shock.                                                                                                  
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DISSEMINATED INTRAVASCULAR COAGULATION: 
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Early directed resuscitation of patients with sepsis may prevent 
the progression from prerenal azotemia to acute tubular necrosis. 
Maintenance of blood glucose levels below 145 mg per deciliter (8.0 
mmol per liter) may decrease the incidence of acute renal failure, 
multiple-organ dysfunction syndrome, and death. Finally, activated 
protein C can decrease disseminated intravascular coagulation with 
glomerular and microvascular thrombi and thereby decrease mortality. T 
bars indicate inhibition. 
Role of glucocorticoids:  
Glucocorticoids have been known to enhance the pressor effects 
of catecholamines, but older studies in which septic shock was treated 
with large doses of glucocorticoid hormones for a short period of time 
did not show any benefit63,64. However, a recent study65 in patients with 
septic shock showed that patients without a response to corticotropin (as 
defined by a rise in plasma free cortisol of less than 9 μg per deciliter at 
30 or 60 minutes) who were treated for 7 days with intravenous boluses 
of 50 mg of hydrocortisone every 6 hours plus daily oral fludrocortisone 
(a 50-μg tablet) had a decrease in mortality at 28 days as compared with 
the placebo group (63 percent vs. 53 percent, P=0.02). In this 
randomized study, 229 of the 299 patients with septic shock who were 
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enrolled were classified as not having a response. There was no 
difference in mortality among the 70 patients with a response to the 
short corticotropin study. Withdrawal of vasopressors was also 
significantly better at 28 days in those without a response (40 percent vs. 
57 percent, P<0.001)65. Although this study did not report renal function 
results, it is known that septic shock is associated with acute renal 
failure in 38 percent of patients with negative cultures and 51 percent of 
patients with positive cultures2. 
Role of mechanical ventilation:  
 Studies show that the longer the duration of mechanical 
ventilation, the higher the mortality in patients with sepsis and acute 
renal failure. 
One study showed that daily interruption of a continuous infusion 
of sedatives in critically ill patients who were undergoing mechanical 
ventilation shortened the time needed on the ventilator (7.3 vs. 4.9 days, 
P=0.004) and time in the intensive care unit (9.9 vs. 6.4 days, P=0.02). 
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Renal replacement therapy:  
Patients with sepsis and acute renal failure are hypercatabolic. 
Studies suggesting that increased doses of dialysis improve survival in 
patients who are hypercatabolic and have acute renal failure are 
persuasive. For example, survival was markedly improved with 
aggressive hemodialysis as compared with peritoneal dialysis in patients 
who had heatstroke, rhabdomyolysis, and acute renal failure. 
Hemofiltration has been shown to produce better survival rates than 
peritoneal dialysis in patients with acute renal failure associated with 
malaria and other infections. A recent study showed that daily 
hemodialysis as compared with alternate-day hemodialysis was 
associated with less systemic inflammatory response syndrome or sepsis 
(22 percent vs. 46 percent, P=0.005), lower mortality (28 percent acute 
renal failure (mean [±SD], 9±2 vs. 16±6 days; P=0.001). 
Continuous renal-replacement therapy has increasingly been used 
to treat acute renal failure. A randomized study using continuous 
venovenous hemofiltration suggested that the ultrafiltration rate of 35 or 
45 ml per kilogram per hour as compared with 20 ml per kilogram per 
hour improves survival in acute renal failure (P<0.001)70. Moreover, in 
patients with sepsis-related acute renal failure, better survival was 
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observed with an ultrafiltration rate of 45 ml per kilogram per hour than 
with a rate of 35 mg per kilogram per hour. Meta-analysis of 
hemodialysis as compared with continuous renal-replacement therapy in 
acute renal failure, however, has not yet shown an advantage for either 
mode of renal replacement therapy71. The benefit of the removal of 
cytokines by continuous renal-replacement therapy also remains to be 
proven as a method for improving survival in patients with sepsis and 
acute renal failure. 
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AIMS AND OBJECTIVES 
 
To study profile of sepsis with acute kidney injury. 
To study the relationship between age, sex and its clinical outcome. 
To study about the influence of renal replacement therapy employed.  
To assess the mortality rates of septic patients. 
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MATERIALS AND METHODS 
 
Place  :  Department of Medicine, Kilpauk medical college  
   and Hospital And Department of Nephrology,  
   Kilpauk medical college and Hospital 
Design :  Observational study 
Duration :  November 2010- November2011 
Sample size:  50 patients 
Inclusion criteria:  
All patients with evidence of sepsis and acute kidney injury above 
13yrs of age, both male and female  
Sepsis criteria:  
Sepsis-   Body temperature > 38° Celsius or < 36° Celsius  
               Heart rate > 90 beats/minute 
               Respiratory rate > 24/minute 
               Immature band forms  
Plus 
               Evidence of infection by culture sensitivity, gram stain 
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Severe sepsis -   Sepsis plus one organ dysfunction  
1. Cardiovascular: arterial systolic blood pressure 90mmhg or mean 
arterial pressure 70mmhg that responds to administration of 
intravenous fluids.  
2. Renal: urine output < 0.5ml/kg/hour for 1 hour despite adequate fluid 
resuscitation.  
3. Respiratory: Pao2/Fio2 < 250 or if the lung is the only dysfunctional 
organ < 200 
4. Hematologic: platelet count < 80,000/l or 50% decrease in platelet 
count from the highest value recorded over previous 3 days.  
5. Unexplained metabolic acidosis: A pH 7.30 or base deficit 5.0 mEq/l 
and plasma lactate level > 1.5 time’s upper limit of normal for 
reporting lab.  
6. Adequate fluid resuscitation: pulmonary artery edge pressure 12 
mmHg or central venous pressure 8 mmHg.  
Septic shock:  
Sepsis with hypotension( arterial blood pressure < 90 mmHg 
systolic or 40mmHg less than patients normal blood pressure) for at 
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least 1 hour despite adequate fluid resuscitation or need for 
vassopressors to maintain blood pressure 90 mmHg or mean arterial 
pressure 70mmHg.  
Acute kidney injury criteria:  
RIFLE CRITERIA:  
 GFR criteria Urine output criteria 
Risk  
 
Increased cr×1.5 or 
GFR>25% decrease 
or absolute increase in 
sr.cr of 0.3mg/dl 
<5ml/kg/hr for 6hrs 
Injury 
 
Increased cr×2 or 
GFR >50% decrease 
<5ml/kg/hr×12hrs 
Failure 
 
Increased cr×3 or 
GFR>75% decrease 
or sr cr>4mg/dl 
<3ml/kg/hr×12hrs or 
anuria for 12 hrs 
Loss 
 
Persistent AKI >4 
Weeks 
  
ESRD Persistent renal failure 
>3months 
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Exclusion criteria: 
Patients with chronic kidney disease 
Procedure of the study:  
Patients admitted in medical, surgical, obstetrics and gynaecology 
ward and nephrology ward with clear evidence of sepsis and acute 
kidney injury assessed by raised titres of serum creatinine and reduced 
urine output as per RIFLE CRITERIA. Septic patients are classified into 
three groups as moderate sepsis, severe sepsis and septic shock as per 
classification given American thoracic society. Detailed and meticulous 
history has been taken from patients and from attenders. A through 
clinical examination is also carried out. The following parameters were 
evaluated from the recruited patients 
1. Complete blood count with peripheral smear 
2. Urine routine 
3. Temperature recorded using mercury thermometer 
4. Serial values of serum urea and serum creatinine 
5. Serum sodium and serum potassium 
6. Urine output and input chart 
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7. Chest x-ray pa view 
8. Urine spot protein- creatinine ratio 
9. Ultrasound abdomen and pelvis 
10. Urine/blood/sputum culture and sensitivity 
11. CSF analysis, if needed 
12. Arterial blood gas analysis 
13. 12-lead ECG 
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DATA ANALYSIS 
SEX DISTRIBUTION:  
Sex No of cases Percentage 
Male 29 58% 
Female 21 42% 
Total 50 100% 
 
As per this table, there are 21 cases of female patients (42%) and 
29 cases of male patients (58%). 
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AGE DISTRIBUTION:  
Age Frequency Percentage 
25-34 7 14% 
35-44 17 34% 
45-54 4 8% 
55-64 8 16% 
65-74 8 16% 
75-85 6 12% 
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CORRELATION BETWEEN AGE AND SEVERITY OF SEPSIS: 
Severity of sepsis No of cases Mean Age 
Moderate 20 38.65 
Severe 19 54.79 
Shock 11 69.27 
Total 50 51.52 
 
 
 
As per this table, 20 cases of moderate sepsis with mean age of 
38.6, 19 cases of severe sepsis with mean age of 54.7 and 11 cases of 
septic shock with mean age of 69.2. With increasing age there 
increasing severity of sepsis (p value <0.001) 
38 
 
AGE VERSUS THE OUTCOME: 
Outcome No of cases Mean Age 
Expired 20 64.5 
Chronic kidney disease 11 45.27 
Recovered 19 41.47 
Total 50 51.52 
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RENAL REPLACEMENT THERAPY USED IN SEPTIC AKI 
CASES: 
RRT 
SEVERITY OF SEPSIS Total 
Moderate Severe Shock 
Conservative 
Management  
 
18 
 
4 
 
3 
 
25 
Haemodialysis  1 7 4 12 
Peritoneal 
dialysis 
 
1 
 
8 
 
4 
 
13 
Total 20 19 11 50 
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OLIGURIC AKI AND NON-OLIGURIC AKI MORTALITY 
ASSESSMENT:  
Oliguria 
Outcome 
Total CKD Expired Recovered 
  No  
(Non-Oliguric) 7 1 14 22 
    Yes 
(Oliguric)   4 19 5 28 
 
 
Chi-Square Tests
20.862 2 .000
50
Pearson Chi-Square
N of Valid Cases
Value df P-value
 
As per above evaluation, Acute kidney injury in septic patients 
with oliguria has increased than non-oliguric AKI (p value<0.0001) 
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RRT AND ITS OUTCOME 
RRT 
Outcome 
Total %    CKD  Expired Recovered
Conservative 
Management 6 5 14 25 50% 
Haemodialysis 2 8 2 12 24% 
Peritoneal 
dialysis 3 7 3 13 26% 
 
 
Chi-Square Tests
9.795 4 .044
50
Pearson Chi-Squar
N of Valid Cases
Value df P-value
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CAUSE OF SEPSIS WITH AKI 
Causes percentage 
1. Thoracic  38% 
2. Intra-abdominal 30% 
3. Genito-urinary 12% 
4. Skin/soft-tissue/wounds  10% 
5. Central nervous system 6% 
6. Others 4% 
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CAUSE OF SEPSIS VERSUS SEVERITY OF SEPSIS 
SEPSIS 
(Severity) 
 
 
                                Cause of sepsis  
Thoracic  Intra-
abdominal
Genito-
urinary
Skin/soft 
tissue 
CNS Others
Moderate 
 
   10       3        3      1     2    1 
Severe  
 
    7       6     3      2   0    1 
Shock  
 
    2       6     0      2   1    0 
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SEVERITY OF SEPSIS VERSUS OUTCOME 
Outcome 
 
 
Severity of Sepsis 
Total %Moderate Severe  Shock  
Recovered       14       5      0    19 38 
% within sepsis       70%      26.3%     0% 
CKD        6       4      1     11  22 
% within sepsis      30%     36.4%     9.1% 
Expired         0      10      10    20 40 
% within sepsis       0%       52.6%      90.9% 
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Chi-Square Tests
27.560 4 .000
50
Pearson Chi-Square
N of Valid Cases
Value df P-value
 
Septic shock cases have 90% mortality, followed by 53% 
mortality seen in severe sepsis. 70% of cases recovered in moderated 
sepsis and 26% cases recovered from severe sepsis.30% of cases landed 
up in developing CKD in moderate sepsis and 21% in severe sepsis. 
Mortality rate increases with severity of sepsis (p value <0.0001) 
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DISCUSSION 
Sepsis is one of the most important causes of In-hospital 
mortality. The mortality rate goes higher when there is association with 
acute kidney injury and failure. Though, there are western studies and 
articles to quote this, studies in India are lacking. The prognosis also 
depends upon the number of organs involved in dysfunction, mechanical 
ventilation, age, sex, severity of sepsis and co-morbid states. Mortality 
in sepsis is varying from one study group to other and as quoted by H 
Neveu et al6, Mortality ranges from 55 to 89%6.  Here, we analysis other 
western studies to our findings.  
Sex distribution as per our study, males predominate by 58% and 
females by 42%. 
Studies Males (%) Females (%) Mean age 
Sean M Bagshaw 
et al8 
61.9% 38.1% 58.6 
H.Neveu et al6 59% 41% 62.2 
Jose Antonio lopes 
et al7 
56% 44% 61.8 
 
Our study 58% 42% 51.1 
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Those three studies studied in large group of patients also 
demonstrated the male preponderance and the mean age in our study 
was 51.1 which is lower than those three studies.  
Neveu et al6, grouped the septic patients into septic syndrome and 
septic shock and demonstrated the profile of this patients with acute 
kidney injury. He demonstrated, septic patients with older age group 
have higher mortality than the control group6. We have also 
demonstrated that with increasing the age, there is also increase in 
mortality. This idea was also shared by jose Antonio lopes et al7, in his 
study he classified the renal impairment cases into risk, injury, failure 
based on RIFLE classification. In this study, mean age for risk, injury, 
failure are 61.9, 61.6, 61.8 respectively7. Age versus mortality was 
27.3% in risk, 28.6% in injury and 55% in failure group7. This clearly 
depicts that with increasing age there is an increase in mortality.  
Regarding the sex distribution, these three studies clearly depicts male 
sex are more likely to be affected by septic AKI than females. But, 
search of articles revealed another study done by Bagshaw et al8, posted 
in critical care medicine journal states female preponderance, old age 
and associated with co-morbidities have increased mortality. Lopes et 
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al7, has demonstrated old age patients have septic shock when compared 
to sepsis syndrome patients. This correlates with our study. 
Oliguria and septic AKI are well correlated in Bagshaw et al8 and 
in Neneu et al6, which also demonstrated that oliguric AKI has higher 
mortality than non-oliguric AKI. They have also demonstrated that 
oliguria is more common in septic AKI than Non-septic AKI. In our 
study, 56% of cases have oliguria and 44 % have non-oliguric Septic 
AKI. Oliguric septic AKI is associated with 95% mortality rate.  
Regarding renal replacement therapy in septic AKI, continuous 
renal replacement therapy versus intermittent haemodialysis is still a 
controversial one. Bagshaw et al (2008;JAMA), concluded by saying 
continuous renal replacement therapy is ideal choice but pannu et al, 
gave contradictory reports claiming that intermittent renal replacement 
therapy is more cost effective and decreases over all mortality. But, in 
our setting due to financial restrictions only intermittent renal 
replacement therapy is available. With  our limited available of 
resources, intermittent haemodialysis and peritoneal dialysis in special 
cases and those who present with moderate sepsis with adequate urine 
output are managed conservatively. In our study, totally 50% are 
managed conservatively, 24% by haemodialysis and 26% by peritoneal 
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dialysis. We observed that patients requiring replacement therapy have 
higher mortality than the conservative group, however the patients in 
intervention group are ideal candidates for RRT, which composites of 
septic shock and severe septic patients (p value <0.04). This view was 
supported by H.Neveu et al, demonstrated mortality more in dialysed 
group (82.4%) than non-dialysed groups (59%)(p value <0.01). He also 
demonstrated continuous RRT (86.7%) has higher mortality than 
intermittent RRT (81.4%)(p value <0.01). bagshaw et al, demonstrated 
that with septic AKI continuous RRT was followed and in Non-septic 
AKI intermittent RRT was followed and both groups failed to produce 
any significance.  
Etiological factors for sepsis is also studied by bagshaw et al, 
Neveu et al and Hoste et al12, there were no major different ideas. 
Thoracic causes contributing to major portion of septic AKI followed by 
abdominal causes. Hoste et al12, demonstrated lung infection (60%), 
abdominal infection (20%) and others (20%). Bagshaw et al, 
demonstrated, thoracic (30%), abdominal (24.3%), endovascular (6.7%), 
haematological/ oncological/ immunocompromised (5.8%), genito- 
urinary (4.1%), skin (3.5%), CNS causes (1.4%) and others (0.8%). In 
our study, causes of sepsis include Thoracic (38%), intra-abdominal 
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(30%), genito- urinary (12%), skin/soft-tissue and wounds (10%), CNS 
(6%) and others (4%). Thoracic causes predominate in these two 
studies, seen in our study also. Associated co-morbid illness like chronic 
respiratory insufficiency is demonstrated in those patients with  
Septic AKI.  
Sepsis with AKI mortality is assessed with non-septic AKI 
mortality in Neveu et al, demonstrated septic AKI has 74.5% in hospital 
mortality and 89.2% in septic AKI cases with ICU admission mortality. 
It also, demonstrated ICU admission with septic AKI has increased 
mortality than hospital admission septic AKI. 
Bagshaw et al, also demonstrated 78% mortality in septic shock, 
55% in severe sepsis cases. These studies demonstrate that sepsis is 
associated with increased mortality than non-septic AKI cases. These 
results are also collaborating, with our study demonstrating 90% 
mortality in septic shock, 52.5% in severe sepsis cases. 
Sepsis with AKI is also associated with increase in heart rate, 
increase in serum billurubin levels, increase in white cell count, low 
GCS status. Bagshaw et al8, neveu et al6 and hoste et al12, all these 
studies demonstrated good significant values. These values are also 
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demonstrable in our studies. The need for mechanical ventilation is also 
associated with adverse outcome as demonstrated by bagshaw et al.  
Regarding the outcome, the patients are observed for 3 months in 
Nephrology OPD to determine the progression to CKD and complete 
recovery.  
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CONCLUSION 
Sepsis is an independent predictor of mortality in patients 
admitted in both wards and ICU. The mortality is further increased 
when acute renal injury settles in. Sepsis with acute kidney injury has 
high mortality in old age patients than younger patients. Male patients 
have high mortality than female patients.  Septic shock and severe sepsis 
is associated with high mortality than moderate sepsis. Regarding renal 
replacement therapy, controversy prevails between continuous renal 
replacement therapy and intermittent renal replacement therapy for 
sepsis with acute kidney injury patients. However, we studied using 
intermittent haemodialysis and peritoneal dialysis. We had increased 
mortality with haemodialysis than peritoneal dialysis.  Severe sepsis 
patients and septic shock patients with AKI are usually managed with 
interventional therapies. Moderate sepsis patients have good urine 
output, so they are managed conservatively and their general outcome is 
good. Oliguric septic AKI is also associated with high mortality than 
non-oliguric AKI, we need more randomised controlled trials to confirm 
this.  
The pro-forma  
 
NAME:           
AGE/SEX:                                 
IP NO:  
ADDRESS:    
 
OOCUPATION:        
PHONE NO:                                                    
DURATION OF STAY:       
OUTCOME: 
 
 
DIAGNOSIS:  
CHIEF COMPLAINTS:  
H/O PRESENTING ILLNESS: 
PAST H/O:                                                                                      
DRUG H/O: 
DM          SHT       CAD      CKD       
                                               
PERSONAL H/O:   
ALCOHOL        SMOKING         DRUG ABUSE   
ANTHROPOMETRY 
WT:                              HT:                    BMI:    
GENERAL EXAMINATION: 
CONSIOUS LEVEL AT PRESENTATION (GCS): 
PALLOR    CYANOSIS   CLUBBING   ICTERUS    PEDAL EDEMA    
HYDRATION STATUS: 
L/E:  
VITALS: 
BP:                  PR:                   TEMP:   RR:   GCS:  
INVESTIGATIONS: 
CBC:      URINE R/E: 
PHERIPHERAL SMEAR:  SERUM LACTATE:      
MP/MF:                                             ABG:                      
TOXIC GRANULATIONS: 
IMMATURE BAND FORMS (WBC): 
OTHERS:  
URINE C/S:                                                               PUS C/S: 
 
BLOOD C/S:                                                               
 
URINE SPOT PCR:  
 
SEROLOGICAL TESTS AND OTHER TESTS:  
 
RENAL FUNCTION TESTS: 
DATE 
 
       
S.UREA 
 
       
S.CREAT 
 
       
INPUT 
 
       
OUTPUT 
 
       
TOTAL 
COUNT 
       
 
LIVER FUNCTION TESTS: 
Date     
Sr.billurbin    
SGOT    
SGPT    
SAP    
Sr.protein(A/G)    
PT    
 
IMAGING STUDIES: 
CXR:  
         
USG ABDOMEN: 
 
CT ABDOMEN: 
 
OTHERS: 
 
 
 
RIFLE CRITERIA FOR ACUTE KIDNEY INJURY 
 
 GFR Criteria Urine output 
Criteria 
Conclusion 
Risk Increased cr×1.5 or 
GFR>25% decrease 
or absolute increase 
in sr.cr of 0.3mg/dl 
<5ml/kg/hr for 
6hrs 
 
Injury Increased cr×2 or 
GFR >50% 
decrease 
<5ml/kg/hr×12hrs  
Failure Increased cr×3 or 
GFR>75% decrease 
or sr cr>4mg/dl 
<3ml/kg/hr×12hrs 
or anuria for 12 hrs
 
Loss Persistent AKI >4 
Weeks 
   
ESRD >3months   
 
 
 
 
 
 
SEPSIS CRITERIA   
 Observed Inference 
Sepsis: 
1.Temp>38deg cel or <36deg cel 
2.heart rate>90/mt 
3.RR>24/mt 
4.wbc count >12000 or < 
4000cell/cu.mm 
5.immature band forms 
Evidence of infection                        
  
Severe sepsis: 
Sepsis +  
One organ dysfunction 
1.CVS-- SBP <90mmhg or 
MAP<70mmhg responds to IVF 
2.RENAL—UO<5ml/kg/hr 
despite IVF 
3.haematological—plt 
count<80,000/l or 50% reduction 
from previous value for the past 3 
days 
4.unexplained metabolic acidosis 
5.adequete fluid resuscitation  
  
Septic shock: 
sepsis with hypotension 
SBP<90mmhg or MAP<70mmhg 
despite adequate fluid 
resuscitation and inotropes. 
  
OUTCOME 
Dialysis requiring Non-dialysis requiring(conservative 
management) 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 1 Patient undergoing Haemodialysis 
 Figure 2 Haemodialysis machine in Nephrology Department 
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NAME AGE/SEX IP NO DURATION CAUSE OF SEPSIS RIFLE SEPSIS OLIGURIC SBP HR GCS S.billurubin TOTAL COUNTS RRT OUTCOME
Asirvatham 63/M 20456 20 UTI INJURY MODERATE NO 110 112 15 1 11,100 HD CKD
Selvi 28/F 23902 26 PUPERAL SEPSIS FAILURE SHOCK YES 90 132 12 2.1 12,300 HD EXPIRED
Suresh 17/M 21097 15 APPENDIX ABCESS INJURY MODERATE NO 120 124 14 1.3 10,800 CONSERVE RECOVERED
Arasu 59/M 19865 21 PNEUMONIA INJURY SEVERE YES 100 115 12 1.8 11,250 PD CKD
Shanthi 65/F 19546 28 CVA/BEDSORES FAILURE SHOCK YES 80 115 9 1.4 12,015 PD EXPIRED
Arulraj 62/M 22976 18 PNEUMONIA FAILURE SEVERE NO 115 124 11 1.2 11,820 CONSERVE CKD
Rekha 53/F 21087 22 ACU.CHOLECYSTITIS INJURY MODERATE NO 130 124 15 3.1 13,250 CONSERVE RECOVERED
Ranganathan 44/M 23765 18 LUNG ABCESS INJURY MODERATE NO 128 124 15 1.5 10,250 CONSERVE RECOVERED
Ponraj 57/M 23128 22 EMPYEMA INJURY MODERATE NO 125 112 15 1.5 10,800 CONSERVE RECOVERED
Paul 61/M 23671 19 LIVER ABCESS FAILURE SHOCK YES 92 130 13 2.2 11,235 HD EXPIRED
Antony 33/M 19831 18 DCLD/SBP INJURY SEVERE YES 98 121 12 3.4 11,150 HD RECOVERED
Vijay 29/M 19429 26 PYELONEPHRITIS/HIV INJURY SEVERE YES 90 122 14 1.5 12,300 CONSERVE EXPIRED
Santhanam 38/M 19476 15 MENIGITIS INJURY MODERATE NO 112 110 15 0.8 11,015 CONSERVE RECOVERED
Vanitha 71/F 18743 14 PNEUMONIA INJURY SEVERE YES 92 129 13 2.3 12,810 PD EXPIRED
Valli 66/F 18643 13 PNEUMONIA INJURY MODERATE NO 114 111 15 0.9 11,140 CONSERVE CKD
Durai 58/M 28745 20 DM ULCER INJURY MODERATE NO 110 112 15 0.8 10,500 CONSERVE CKD
palani 52/M 18763 14 LUNG ABCESS INJURY MODERATE YES 120 104 15 1.3 10,200 PD RECOVERED
begum 64/F 19845 19 MENIGITIS FAILURE SHOCK YES 90 129 12 1.5 11,800 PD EXPIRED
selvi 81/F 25432 20 PYELONEPHRITIS FAILURE SEVERE YES 100 124 13 1.4 11,200 HD EXPIRED
anbu 55/M 21903 21 ILLEAL PERFORATION INJURY SHOCK YES 81 132 11 1.3 12,100 CONSERVE EXPIRED
rafiq 32/M 20342 17 LIVER ABCESS INJURY SEVERE YES 94 124 10 2.1 12,235 HD EXPIRED
amirthan 79/M 20032 23 CVA/BEDSORES FAILURE SEVERE NO 100 102 9 1.2 10,390 PD EXPIRED
amala 51/F 21984 12 CVA/UTI INJURY MODERATE NO 130 100 8 1.3 10,310 CONSERVE RECOVERED
sathya 29/M 23985 14 UTI/HIV INJURY MODERATE NO 130 102 12 1 9,500 CONSERVE CKD
mala 35/F 25984 11 LSCS WOUND SEPSIS FAILURE SEVERE YES 90 135 10 2.1 11,500 HD EXPIRED
jyothi 38/F 21942 21 LSCS WOUND SEPSIS INJURY MODERATE NO 120 120 15 0.7 11,000 CONSERVE RECOVERED
basha 42/M 21958 19 ENCEPHALITIS INJURY MODERATE NO 120 100 11 0.7 10,200 CONSERVE CKD
subramani 53/M 21748 18 PNEUMONIA INJURY MODERATE NO 110 104 15 1.2 10,302 CONSERVE RECOVERED
asairaj 69/M 24953 12 PNEUMONIA INJURY SEVERE YES 102 105 11 1.5 12,800 PD EXPIRED
christopher 62/M 21940 14 EMPYEMA INJURY MODERATE NO 110 102 15 1 11,100 CONSERVE CKD
elizabeth 42/F 18734 13 PYELONEPHRITIS INJURY SEVERE YES 100 115 11 1.2 11,300 HD CKD
kamala 66/F 18721 11 ACU.CHOLECYSTITIS FAILURE SHOCK YES 90 113 13 1.4 13,000 HD EXPIRED
Arul 57/M 18943 10 PNEUMONIA INJURY MODERATE NO 120 100 15 1.2 10,500 CONSERVE RECOVERED
selva 52/M 18745 19 PERITONITIS FAILURE SHOCK YES 93 130 12 1.4 12,500 CONSERVE EXPIRED
christy 62/F 19345 14 PERITONITIS FAILURE SEVERE YES 100 129 10 1.5 13,150 CONSERVE EXPIRED
ezhilvizhi 84/F 19245 21 PNEUMONIA FAILURE SEVERE YES 98 132 12 1.4 11,015 PD EXPIRED
thamaraikani 73/F 17453 22 DCLD/SBP FAILURE SEVERE NO 103 135 10 3.2 10,500 CONSERVE RECOVERED
reshma 29/F 23092 12 VSD/IE INJURY MODERATE NO 110 122 15 1.2 11,000 CONSERVE RECOVERED
razia 68/F 14973 21 PNEUMONIA INJURY MODERATE NO 125 122 15 0.8 11,000 CONSERVE RECOVERED
rani 56/F 23956 22 PNEUMONIA FAILURE SEVERE YES 95 121 12 1.2 12,250 PD RECOVERED
sekar 59/M 27635 14 DM ULCER FAILURE SEVERE YES 100 131 14 0.8 13,550 PD CKD
mohammed 61/M 29834 21 LUNG ABCESS FAILURE SHOCK YES 94 135 12 1.5 12,500 PD EXPIRED
malar 58/M 25693 20 VSD/IE INJURY SEVERE YES 80 132 14 1.5 11,000 HD RECOVERED
john 70/M 24780 19 EMPYEMA INJURY MODERATE NO 110 110 15 1.2 11,015 CONSERVE RECOVERED
chinna 68/M 24863 19 PNEUMONIA INJURY MODERATE NO 129 105 15 1.1 10,900 CONSERVE RECOVERED
muthu 66/M 27834 13 ILLEAL PERFORATION FAILURE SHOCK YES 85 132 11 1.4 13,500 CONSERVE EXPIRED
rabia 35/F 21053 13 EMPYEMA INJURY SEVERE YES 105 134 13 1.1 12,850 PD RECOVERED
begum 36/F 27463 14 DM ULCER FAILURE SHOCK YES 90 129 10 1 11,500 PD CKD
joseph 42/M 21749 21 DCLD/SBP INJURY SEVERE YES 92 129 12 1.1 10,500 HD EXPIRED
rajathi 53/F 21749 21 PNEUMONIA FAILURE SHOCK YES 90 123 10 1.5 11,540 HD EXPIRED
